Citation Information :
Monni G, Ibba RM, Cau G, Murgia F. 40 Years of Experience in Invasive Prenatal Genetic Diagnosis. Donald School J Ultrasound Obstet Gynecol 2023; 17 (4):349-352.
The field of genetic prenatal diagnosis has seen remarkable advances in terms of prevention of birth defects and genetic diseases in the last 40 years.
This progress is due to the operators’ experience with new genome studies and molecular biology analysis.
In the meantime, the most sophisticated ultrasonography equipment has made it possible to perform fetal procedures in early pregnancy as well as in the preimplantation period, thus making prenatal diagnosis increasingly accepted by couples wishing to plan their offspring and reducing the anxiety of waiting for the diagnostic response, and, in severe cases when chosen by the woman, the possibility of terminating the pregnancy in the first trimester.
In the new era of genetic screening using combined tests and noninvasive prenatal testing (NIPT), we have had a decrease in invasive prenatal diagnostic procedures and a progressive increase in chorionic villus sampling (CVS) compared to amniocentesis for chromosomal indications.
In this paper, we describe the invasive sampling techniques performed at Microcitemico Hospital–Cagliari in the last 40 years by fetal blood sampling (FBS), amniocentesis, CVS, and preimplantation genetic diagnosis (PGD) applied to prevent the most common fetal genetic disorders.
Milunsky A, Milunsky JM. Genetic Disorders and the Fetus, 6th edition. Chichester: Wiley-Blackwell; 2010.
Norton ME, Kuller JA, Dugoff L. Perinatal Genetics. Elsevier; 2019.
Cao A, William Alan Award address. Am J Hum Genet. 1994;54:397–402.
Cao A, Rosatelli MC, Monni G, et al. Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am 2002;29(2):305–328. DOI: 10.1016/s0889-8545(01)00006-7
Monni G, Peddes C, Iuculano A, et al. From prenatal to preimplantation genetic diagnosis of β-Thalassemia. Prevention model in 8748 cases: 40 years of single center experience. J Clin Med 2018;7(2):35. DOI: 10.3390/jcm7020035
Salomon LJ, Sotiriadis A, Wullf CB, et al. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol 2019;54(4):442–451. DOI: 10.1002/uog.20353
Carlson ML, Vora NL. Prenatal diagnosis: screening and diagnostic tools. Obstet Gynecol Clin North Am 2017;44(2):245–256. DOI: 10.1016/j.ogc.2017.02.004
Monni G, Zoppi MA, Axiana C, et al. Changes in the approach for invasive prenatal diagnosis in 35,127 cases at a single center from 1977 to 2004. Fetal Diagn Ther 2006;21(4):348–354. DOI: 10.1159/000092464
Cao A, Falchi AM, Tuveri T, et al. Prenatal diagnosis of thalassemia major by fetal blood analysis: experience with 1000 cases. Prenat Diagn 1986;6(3):159–167. DOI: 10.1002/pd.1970060302
Rosatelli MC, Falchi AM, Tuveri T, et al. Prenatal diagnosis of beta thalassemia with the synthetic-oligomer technique. Lancet 1985;1(8423):241–243. DOI: 10.1016/s0140-6736(85)91026-8
Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012;367(23):2175–2184. DOI: 10.1056/NEJMoa1203382
Monni G, Zoppi MA, Iuculano A, et al. Invasive or non-invasive prenatal genetic diagnosis? J Perinat Med 2014;42(5):545–548. DOI: 10.1515/jpm-2014-0135
Monni G, Corda V, Iuculano A, et al. The decline of amniocentesis and the increase of chorionic villus sampling in modern perinatal medicine. J Perinat Med 2020. DOI: 10.1515/jpm-2020-0035
Monni G, Olla G, Cao A. Patient's choice between transcervical and transabdominal chorionic villus sampling. Lancet 1988;1(8593):1057. DOI: 10.1016/s0140-6736(88)91880-6
Monni G, Ibba RM, Olla G, et al. Chorionic villus sampling by rigid forceps: experience with 300 cases at risk for thalassemia major. Am J Obstet Gynecol 1987;156(4):912–914. DOI: 10.1016/0002-9378(87)90352-8
Monni G, Ibba RM, Lai R, et al. Early transabdominal chorionic villus sampling in couples at high genetic risk. Am J Obstet Gynecol 1993;168(1 Pt 1):170–173. DOI: 10.1016/s0002-9378(12)90908-4
Monni G, Ibba RM, Olla G, et al. Prenatal diagnosis of beta-thalassaemia by second-trimester chorionic villus sampling. Prenat Diagn 1988;8(6):447–451. DOI: 10.1002/pd.1970080609
Monni G, Zoppi MA. Improved first-trimester aneuploidy risk assessment: an evolving challenge of training in invasive prenatal diagnosis. Ultrasound Obstet Gynecol 2013;41(5):486–488. DOI: 10.1002/uog.12461
Monni G, Pagani G, Stagnati V, et al. How to perform transabdominal chorionic villus sampling: a practical guideline. J Matern Fetal Neonatal Med 2016;29(9):1499–1505. DOI: 10.3109/14767058.2015.1051959
Monni G, Corda V, Iuculano A, et al. Efficacy, safety, and success of 18- versus 20-gauge needle for transabdominal chorionic villus sampling in a high-volume training setting. Prenat Diagn 2021;41(1):8–10. DOI: 10.1002/pd.5845
Monni G, Pagani G, Illescas T, et al. Training for transabdominal villous sampling is feasible and safe. Am J Obstet Gynecol 2015;213(2):248–250. DOI: 10.1016/j.ajog.2015.04.019
Monni G, Cau G, Usai V, et al. Preimplantation genetic diagnosis for beta-thalassemia: the Sardinian experience. Prenat Diagn 2004;24(12):949–954. DOI: 10.1002/pd.1051
Palomba ML, Monni G, Lai R, et al. Psychological implications and acceptability of preimplantation diagnosis. Hum Reprod 1994;9(2):360–362. DOI: 10.1093/oxfordjournals.humrep.a138508
Cao A, Cossu P, Monni G, et al. Chorionic villus sampling and acceptance rate of prenatal diagnosis. Prenat Diagn 1987;7(7):531–533. DOI: 10.1002/pd.1970070710